ACA Category Banner

Compliance

This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.

3 Major Health Items Included In Biden’s Budget Request

President Joe Biden proposed an ambitious budget for the next federal fiscal year that includes more money for fighting the opioid epidemic, bolstering public health and several other healthcare items. The budget request to Congress, released Friday, acts as essentially a wish list of priorities for the administration for the next year. It is doubtful ...

Read More

Health Care Legislation Drives HSA Adoption

The IRS isn’t the most nimble of organizations, and it would be a stretch to say that health benefits organizations savor oversight. However, what we have seen recently from the IRS (and Congress) is a dedicated and purposeful movement to expand health savings options.

Read More

MetLife Research Shows Generational Disparity On Which Benefits Matter Most

Baby boomers and their younger colleagues disagree on how the coronavirus pandemic has impacted their work-life balance. Fifty-one percent of millennial and Gen Z workers say their work-life balance is better now than before the pandemic, while only one-quarter of baby boomers say the same, according to MetLife’s 19th annual employee benefit trends study. Employees ...

Read More

As Employees Catch Up on Their Delayed Health Care Needs, Claims Could Surge

At the height of the pandemic, employee health care claims dropped steeply when people avoided visiting doctors' offices. Now as coronavirus vaccinations are widely available, Americans are expected to seek long-delayed care.

Read More

U.S. Urges Pause On Use Of Johnson & Johnson COVID-19 Vaccine After Rare Blood Clotting Cases

Federal authorities on Tuesday recommended that states stop using Johnson & Johnson’s Covid-19 vaccine while an investigation is conducted into six serious cases of clotting problems — one of which was fatal — that were reported among women who received the vaccine. The blood clots are similar to those reported by several European countries after use ...

Read More

Biden Ran On A Health Insurance Public Option, But It’s Not Clear If He Will Include It In His Recovery...

While President Joe Biden tries to steer his mammoth new infrastructure plan through Congress, his administration is planning the next phase of its economic recovery efforts. As the White House prepares to unveil a second proposal focused on education, paid leave and health care, it has given few hints about whether it will include a core Biden ...

Read More

Why Experts Say The Information Blocking Ban Will Be Game Changing For Patients

Starting next week, a new regulation goes into effect that will give patients easier access to their digital health records through their smartphones. But while health IT experts have been calling for interoperability for years, they say this particular rule could finally be a major step in achieving a meaningful level of data sharing far beyond what’s ...

Read More

Red Hot Health Investor Interest in Digital Innovation

In the first quarter of 2021, investors doubled down on digital health, pouring $6.7 billion into the sector and making it the most-funded quarter to date, according to investment firm Rock Health. This year is clearly on track to pass the record-breaking amount of capital raised in 2020 as first-quarter funding approached nearly half of the $14 billion raised through ...

Read More

Biden Pushes For Home Health Medicaid Coverage, $400 Billion In Funding

The Biden administration is calling on Congress to expand access to home and community-based care services covered by Medicaid as part of a multi-billion dollar investment in the “care economy.” The proposal, part of a larger jobs and infrastructure plan unveiled by the White House Wednesday, asks Congress to put $400 billion toward expanding access ...

Read More

Ongoing Trial Shows Pfizer Covid-19 Vaccine Remains Highly Effective After Six Months

The ongoing Phase 3 clinical trial of Pfizer/BioNTech’s coronavirus vaccine confirms its protection remains high for at least six months after the second dose, the companies said Thursday. Protection likely lasts even longer than that, vaccine experts say, but they say having data showing good protection six months after people were vaccinated is good news. ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square